To Jump Start China, Think Commercial: Amgen Ties Knot With Beta Pharma For Vectibix
This article was originally published in PharmAsia News
Executive Summary
Since fixing its eyes on China, Amgen has been scouting the country for deals. Now the first result is in, a JV with local industry darling Beta Pharma to commercialize Vectibix in China.